Literature DB >> 23133824

Current neuroimaging techniques in Alzheimer's disease and applications in animal models.

Linda Zhang1, Raymond Chuen-Chung Chang, Leung-Wing Chu, Henry Ka-Fung Mak.   

Abstract

With Alzheimer's disease (AD) quickly becoming the most costly disease to society, and with no disease-modifying treatment currently, prevention and early detection have become key points in AD research. Important features within this research focus on understanding disease pathology, as well as finding biomarkers that can act as early indicators and trackers of disease progression or potential treatment. With the advances in neuroimaging technology and the development of new imaging techniques, the search for cheap, noninvasive, sensitive biomarkers becomes more accessible. Modern neuroimaging techniques are able to cover most aspects of disease pathology, including visualization of senile plaques and neurofibrillary tangles, cortical atrophy, neuronal loss, vascular damage, and changes in brain biochemistry. These methods can provide complementary information, resulting in an overall picture of AD. Additionally, applying neuroimaging to animal models of AD could bring about greater understanding in disease etiology and experimental treatments whilst remaining in vivo. In this review, we present the current neuroimaging techniques used in AD research in both their human and animal applications, and discuss how this fits in to the overall goal of understanding AD.

Entities:  

Keywords:  ASL; Alzheimer’s disease; MRI; MRS; PET; animal models; biomarkers; neuroimaging

Year:  2012        PMID: 23133824      PMCID: PMC3477739     

Source DB:  PubMed          Journal:  Am J Nucl Med Mol Imaging


  148 in total

Review 1.  Alzheimer's disease: clinical trials and drug development.

Authors:  Francesca Mangialasche; Alina Solomon; Bengt Winblad; Patrizia Mecocci; Miia Kivipelto
Journal:  Lancet Neurol       Date:  2010-07       Impact factor: 44.182

2.  Longitudinal assessment of Alzheimer's beta-amyloid plaque development in transgenic mice monitored by in vivo magnetic resonance microimaging.

Authors:  Niels Braakman; Jörg Matysik; Sjoerd G van Duinen; Fons Verbeek; Reinhard Schliebs; Huub J M de Groot; A Alia
Journal:  J Magn Reson Imaging       Date:  2006-09       Impact factor: 4.813

3.  Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment.

Authors:  R D Terry; E Masliah; D P Salmon; N Butters; R DeTeresa; R Hill; L A Hansen; R Katzman
Journal:  Ann Neurol       Date:  1991-10       Impact factor: 10.422

4.  Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease.

Authors:  R Mayeux; A M Saunders; S Shea; S Mirra; D Evans; A D Roses; B T Hyman; B Crain; M X Tang; C H Phelps
Journal:  N Engl J Med       Date:  1998-02-19       Impact factor: 91.245

5.  Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model.

Authors:  D M Holtzman; A M Fagan; B Mackey; T Tenkova; L Sartorius; S M Paul; K Bales; K H Ashe; M C Irizarry; B T Hyman
Journal:  Ann Neurol       Date:  2000-06       Impact factor: 10.422

6.  In vivo measurement of plaque burden in a mouse model of Alzheimer's disease.

Authors:  Arijitt Borthakur; Tamar Gur; Andrew J Wheaton; Matthew Corbo; John Q Trojanowski; Virginia M-Y Lee; Ravinder Reddy
Journal:  J Magn Reson Imaging       Date:  2006-11       Impact factor: 4.813

7.  A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease.

Authors:  C Janus; J Pearson; J McLaurin; P M Mathews; Y Jiang; S D Schmidt; M A Chishti; P Horne; D Heslin; J French; H T Mount; R A Nixon; M Mercken; C Bergeron; P E Fraser; P St George-Hyslop; D Westaway
Journal:  Nature       Date:  2000 Dec 21-28       Impact factor: 49.962

8.  Risk factors for cerebral hypoperfusion, mild cognitive impairment, and dementia.

Authors:  J S Meyer; G Rauch; R A Rauch; A Haque
Journal:  Neurobiol Aging       Date:  2000 Mar-Apr       Impact factor: 4.673

9.  Primate learning tasks reveal strong impairments in patients with presenile or senile dementia of the Alzheimer type.

Authors:  E Irle; J Kessler; H J Markowitsch; W Hofmann
Journal:  Brain Cogn       Date:  1987-10       Impact factor: 2.310

10.  Age-related non-Gaussian diffusion patterns in the prefrontal brain.

Authors:  Maria F Falangola; Jens H Jensen; James S Babb; Caixia Hu; Francisco X Castellanos; Adriana Di Martino; Steven H Ferris; Joseph A Helpern
Journal:  J Magn Reson Imaging       Date:  2008-12       Impact factor: 4.813

View more
  12 in total

Review 1.  Quantum dot-based nanoprobes for in vivo targeted imaging.

Authors:  Y Zhu; H Hong; Z P Xu; Z Li; W Cai
Journal:  Curr Mol Med       Date:  2013-12       Impact factor: 2.222

2.  A review of neuroimaging biomarkers of Alzheimer's disease.

Authors:  Tinu Varghese; R Sheelakumari; Jija S James; Ps Mathuranath
Journal:  Neurol Asia       Date:  2013       Impact factor: 0.183

3.  Near-infrared fluorescence molecular imaging of amyloid beta species and monitoring therapy in animal models of Alzheimer's disease.

Authors:  Xueli Zhang; Yanli Tian; Can Zhang; Xiaoyu Tian; Alana W Ross; Robert D Moir; Hongbin Sun; Rudolph E Tanzi; Anna Moore; Chongzhao Ran
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-21       Impact factor: 11.205

4.  Design and synthesis of curcumin analogues for in vivo fluorescence imaging and inhibiting copper-induced cross-linking of amyloid beta species in Alzheimer's disease.

Authors:  Xueli Zhang; Yanli Tian; Zeng Li; Xiaoyu Tian; Hongbin Sun; Hong Liu; Anna Moore; Chongzhao Ran
Journal:  J Am Chem Soc       Date:  2013-10-25       Impact factor: 15.419

Review 5.  Molecular imaging strategies for in vivo tracking of microRNAs: a comprehensive review.

Authors:  R Hernandez; H Orbay; W Cai
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

Review 6.  Multimodality imaging of RNA interference.

Authors:  T R Nayak; L K Krasteva; W Cai
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

Review 7.  Pharmacokinetic issues of imaging with nanoparticles: focusing on carbon nanotubes and quantum dots.

Authors:  Hao Hong; Feng Chen; Weibo Cai
Journal:  Mol Imaging Biol       Date:  2013-10       Impact factor: 3.488

Review 8.  Synthesis and biomedical applications of copper sulfide nanoparticles: from sensors to theranostics.

Authors:  Shreya Goel; Feng Chen; Weibo Cai
Journal:  Small       Date:  2013-09-19       Impact factor: 13.281

9.  Positron emission tomography imaging of vascular endothelial growth factor receptor expression with (61)Cu-labeled lysine-tagged VEGF121.

Authors:  Yin Zhang; Hao Hong; Gang Niu; Hector F Valdovinos; Hakan Orbay; Tapas R Nayak; Xiaoyuan Chen; Todd E Barnhart; Weibo Cai
Journal:  Mol Pharm       Date:  2012-11-16       Impact factor: 4.939

10.  Hemodynamic and neuropathological analysis in rats with aluminum trichloride-induced Alzheimer's disease.

Authors:  Szu-Ming Chen; Chi-Chen Fan; Ming-Shiuan Chiue; Chi Chou; Jyh-Horng Chen; Ruey-Shyang Hseu
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.